Partow Kebriaei

机构：The University of Texas MD Anderson Cancer Center, Scripps MD Anderson Cancer Center · ORCID：0000-0002-8607-9404

发表论文 1133 篇 · 总被引 27814 次 · h-index 80

代表论文

• Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia (2025 · Bone Marrow Transplantation · 被引 3)
• Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summary (2025 · Future Oncology · 被引 1)
• Phenotype-Specific Associations Between Graft‑Versus‑Host Disease and Post‑Transplant Outcomes (2026 · Transplantation and Cellular Therapy)
• Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage (2026 · Leukemia)
• Abstract A041: Prognostic significance of post-CAR-T macrocytosis in large B-cell lymphoma (2026 · Blood Cancer Discovery)
• Donor-specific HLA mismatch: haploidentical versus 7/8 mismatched unrelated donor hematopoietic cell transplantation with PTCy (2026 · Bone Marrow Transplantation)